HOWL
Price
$1.07
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
48.01M
33 days until earnings call
SYRE
Price
$15.76
Change
+$0.26 (+1.68%)
Updated
Jul 3 closing price
Capitalization
951.17M
26 days until earnings call
Interact to see
Advertisement

HOWL vs SYRE

Header iconHOWL vs SYRE Comparison
Open Charts HOWL vs SYREBanner chart's image
Werewolf Therapeutics
Price$1.07
Change-$0.00 (-0.00%)
Volume$149.18K
Capitalization48.01M
Spyre Therapeutics
Price$15.76
Change+$0.26 (+1.68%)
Volume$506.67K
Capitalization951.17M
HOWL vs SYRE Comparison Chart in %
Loading...
HOWL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HOWL vs. SYRE commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HOWL is a Hold and SYRE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (HOWL: $1.07 vs. SYRE: $15.76)
Brand notoriety: HOWL and SYRE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HOWL: 25% vs. SYRE: 91%
Market capitalization -- HOWL: $48.01M vs. SYRE: $951.17M
HOWL [@Biotechnology] is valued at $48.01M. SYRE’s [@Biotechnology] market capitalization is $951.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HOWL’s FA Score shows that 1 FA rating(s) are green whileSYRE’s FA Score has 0 green FA rating(s).

  • HOWL’s FA Score: 1 green, 4 red.
  • SYRE’s FA Score: 0 green, 5 red.
According to our system of comparison, HOWL is a better buy in the long-term than SYRE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HOWL’s TA Score shows that 3 TA indicator(s) are bullish while SYRE’s TA Score has 5 bullish TA indicator(s).

  • HOWL’s TA Score: 3 bullish, 5 bearish.
  • SYRE’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SYRE is a better buy in the short-term than HOWL.

Price Growth

HOWL (@Biotechnology) experienced а -6.14% price change this week, while SYRE (@Biotechnology) price change was -1.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

HOWL is expected to report earnings on Aug 07, 2025.

SYRE is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYRE($951M) has a higher market cap than HOWL($48M). HOWL YTD gains are higher at: -27.703 vs. SYRE (-32.302). HOWL has higher annual earnings (EBITDA): -65.72M vs. SYRE (-214.36M). SYRE has more cash in the bank: 565M vs. HOWL (92M). SYRE has less debt than HOWL: SYRE (0) vs HOWL (37M). HOWL has higher revenues than SYRE: HOWL (1.14M) vs SYRE (0).
HOWLSYREHOWL / SYRE
Capitalization48M951M5%
EBITDA-65.72M-214.36M31%
Gain YTD-27.703-32.30286%
P/E RatioN/A1.72-
Revenue1.14M0-
Total Cash92M565M16%
Total Debt37M0-
FUNDAMENTALS RATINGS
SYRE: Fundamental Ratings
SYRE
OUTLOOK RATING
1..100
57
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
84
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HOWLSYRE
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
N/A
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 10 days ago
90%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
HOWL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAL14.030.15
+1.08%
Caleres
XRAY16.670.10
+0.60%
DENTSPLY SIRONA
UNH308.550.99
+0.32%
Unitedhealth Group
EVI22.89N/A
N/A
EVI Industries
KLRS2.50-0.06
-2.34%
Kalaris Therapeutics Inc

HOWL and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOWL has been loosely correlated with GBIO. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if HOWL jumps, then GBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOWL
1D Price
Change %
HOWL100%
N/A
GBIO - HOWL
46%
Loosely correlated
+1.51%
IPSC - HOWL
43%
Loosely correlated
+0.02%
CLDX - HOWL
43%
Loosely correlated
-0.50%
ARCT - HOWL
43%
Loosely correlated
+1.17%
SYRE - HOWL
40%
Loosely correlated
+1.68%
More

SYRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYRE has been loosely correlated with CGON. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if SYRE jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYRE
1D Price
Change %
SYRE100%
+1.68%
CGON - SYRE
58%
Loosely correlated
+2.09%
BEAM - SYRE
58%
Loosely correlated
+0.65%
XNCR - SYRE
55%
Loosely correlated
+1.45%
APGE - SYRE
53%
Loosely correlated
N/A
IDYA - SYRE
53%
Loosely correlated
+0.82%
More